| | Response Percent | Response Count |
|---|
| Dan Baxter, Bristol-Myers Squibb | | 2.5% | 2 |
| Faith Busch, Boehringer Ingelheim | | 3.8% | 3 |
| Peter Dannenfelser, Johnson & Johnson | | 1.3% | 1 |
| Craig DeLarge, Novo Nordisk | | 2.5% | 2 |
| Devon Eyer, Johnson & Johnson | | 2.5% | 2 |
| Lisa Flaiz, Janssen | | 1.3% | 1 |
| Alexandra Fulford, Novartis | | 22.8% | 18 |
| Kai Gait, GSK | | 0.0% | 0 |
| Johanna Glaser, Roche | | 1.3% | 1 |
| Shwen Gwee (formerly with Vertex Pharmaceuticals) | | 2.5% | 2 |
| Rob Halper, Johnson & Johnson | | 0.0% | 0 |
| Jennifer Kokell, Pfizer | | 1.3% | 1 |
| Laura Kolodjeski, Sanofi US | | 30.4% | 24 |
| Sabine Kostevc (formerly with Roche Pharmaceuticals) | | 0.0% | 0 |
| Jim LeFevere, Roche Diagnostics | | 0.0% | 0 |
| Gary Monk (formerly with Janssen Cilag) | | 0.0% | 0 |
| Marc Monseau (formerly with Johnson & Johnson) | | 3.8% | 3 |
| Ambre Morley, Novo Nordisk | | 1.3% | 1 |
| Kevin Nalty (formerly with Johnson & Johnson) | | 1.3% | 1 |
| Brad Pendergraph (formerly with Novartis Pharmaceuticals) | | 3.8% | 3 |
| John Pugh, Boehringer Ingelheim | | 3.8% | 3 |
| Len Starnes (formerly with Bayer Schering Pharma) | | 10.1% | 8 |
| Dennis Urbaniak, Sanofi-Aventis | | 35.4% | 28 |
| Someone Else. See my nomination in the answer to the following question. | | 13.9% | 11 |
Add comments about the people in this list that you have nominated. | 14 |